Pharmaceuticals News and Research

RSS

New mouse model shows potential for rapid identification of promising muscular dystrophy therapies

A Massachusetts General Hospital research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be successful.

13 Dec 2018

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Dr. John McCafferty celebrates the success of phage display technology with Nobel Prize in Chemistry Laureates.

From FairJourney Biologics 12 Dec 2018

Deprescribing could help manage polypharmacy in older adults

Reducing the number of medications older adults use can have surprising benefits, according to research presented in a new issue of the journal Public Policy & Aging Report from The Gerontological Society of America.

6 Dec 2018

Optimization of drug dose sizes can reduce pharmaceutical wastage

Pharmaceuticals are often dosed according to patient weight or body size which means that a dose must be individually measured. In a new study, lead author Anthony Hatswell of Delta Hat Limited and University College London in the UK, shows that by optimizing drug dose sizes available, wastage can be cut by as much as 50 percent.

6 Dec 2018

Study of infrequent cannabis users compares adverse effects of vaping and smoking

In a small study of infrequent cannabis users, Johns Hopkins Medicine researchers have shown that, compared with smoking cannabis, vaping it increased the rate of short-term anxiety, paranoia, memory loss and distraction when doses were the same.

4 Dec 2018

Oils from garlic and other herbs show strong killing activity against Lyme disease bacteria

Oils from garlic and several other common herbs and medicinal plants show strong activity against the bacterium that causes Lyme disease, according to a study by researchers at Johns Hopkins Bloomberg School of Public Health.

3 Dec 2018

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications.

3 Dec 2018

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Sartorius Stedim Biotech, a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration.

3 Dec 2018

Insilico Medicine to present work on AI for Drug Discovery at the AI World Conference

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at the AI World Conference in Boston on December 4th.

30 Nov 2018

Podcast: KHN’s ‘What the Health?’ Reading the tea leaves in blue wave’s wake

This week, "What the Health?" panelists discuss, among other things, how the House Democrats' leadership battle could affect the congressional health policy agenda.

29 Nov 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

Scientists develop new technique for identifying small molecules

A UCLA-led team of scientists has developed a new technique that will enable researchers to easily and quickly determine the structures of organic molecules using very small samples.

28 Nov 2018

Report outlines inequalities in access to healthcare

The European Social Policy Network, which is funded by the European Commission and managed jointly by LISER, Applica and the European Social Observatory, has just published a Synthesis Report describing the main features of health systems in terms of access to healthcare in 35 European countries.

21 Nov 2018

Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene

Researchers and clinicians through a multicenter collaboration have identified a novel multisystem disorder caused by bi-allelic variants in the CCDC47 gene. Their findings are reported in the American Journal of Human Genetics.

20 Nov 2018

Cytocybernetics receives NIMH award to move into neuronal drug development

Cytocybernetics, a University at Buffalo spinoff, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

20 Nov 2018

UK health policies should be redesigned to become more accessible for men

UK health policies should be redesigned to become more accessible for men, according to a new report by the Work Foundation.

19 Nov 2018

Human drugs alter cricket personality

Crickets that are exposed to human drugs that alter serotonin levels in the brain are less active and less aggressive than crickets that have had no drug exposure, according to a new study led by researchers from Linköping University. The findings have been published in Scientific Reports.

18 Nov 2018

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals' Arsenic Trioxide Injection is available as 10 mg per 10 mL vial for injection.

16 Nov 2018

Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals

Enable Injections, Inc., a patient-centric drug delivery combination product company developing advanced wearable devices for subcutaneous delivery of high-volume therapeutics, today announced it has entered into development agreements with Apellis Pharmaceuticals, and most recently, UCB.

14 Nov 2018

Salk researchers report new methods to identify AD drug candidates with anti-aging properties

Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds.

14 Nov 2018

Pharmaceuticals News and Research

New mouse model shows potential for rapid identification of promising muscular dystrophy therapies

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Deprescribing could help manage polypharmacy in older adults

Optimization of drug dose sizes can reduce pharmaceutical wastage

Study of infrequent cannabis users compares adverse effects of vaping and smoking

Oils from garlic and other herbs show strong killing activity against Lyme disease bacteria

Scientist.com and Allele Biotechnology partner to develop therapeutic nanoantibodies

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Insilico Medicine to present work on AI for Drug Discovery at the AI World Conference

Podcast: KHN’s ‘What the Health?’ Reading the tea leaves in blue wave’s wake

FDA approves new drug for treatment of rare autoimmune disorder

Scientists develop new technique for identifying small molecules

Report outlines inequalities in access to healthcare

Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene

Cytocybernetics receives NIMH award to move into neuronal drug development

UK health policies should be redesigned to become more accessible for men

Human drugs alter cricket personality

Nexus announces availability of Arsenic Trioxide Injection in the US

Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals

Salk researchers report new methods to identify AD drug candidates with anti-aging properties

Free eBook - From lab to market: Accelerate your bioprocessing journey eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring